Hebei Changshan Biochemical Pharmaceutical Co., Ltd. (SHE:300255)

China flag China · Delayed Price · Currency is CNY
20.15
-0.07 (-0.35%)
Feb 28, 2025, 2:45 PM CST
59.04%
Market Cap 18.58B
Revenue (ttm) 1.05B
Net Income (ttm) -844.59M
Shares Out 919.06M
EPS (ttm) -1.09
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 23,535,752
Average Volume 24,552,396
Open 20.27
Previous Close 20.22
Day's Range 20.07 - 20.95
52-Week Range 8.65 - 25.88
Beta 0.08
RSI 57.77
Earnings Date Apr 28, 2025

About SHE:300255

Hebei Changshan Biochemical Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of crude heparin, heparin raw materials, and heparin preparations for the treatment of cardiovascular and cerebrovascular diseases in China and internationally. It offers crude heparin sodium, heparin sodium raw materials, heparin sodium injections, low molecular weight heparin calcium raw materials and injections, enoxaparin sodium raw materials and injections, nadri heparin calcium API, nandroparin calcium injection, and dalteparin ... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2000
Employees 1,410
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 300255
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.